Why the study?
Long-term oxygen therapy alters the late course of COPD and is increasingly prescribed, but the common barriers preventing adequate compliance needed to be recognized.
Adherence to long-term oxygen therapy in COPD patients in Kashmir is extremely poor (21.4%), largely driven by inadequate physician counseling and practical difficulties with oxygen delivery systems.
Identifying barriers to LTOT adherence in COPD may guide education; leaves open whether interventions improve compliance.
COPD is a growing global threat considering its increasing prevalence, morbidity and mortality. The only modality of treatment that has been proven to alter the late course of this disease is the long term oxygen therapy (LTOT). Considering that an increasing number of COPD patients are getting a prescription of LTOT, this study was done to recognize the common barriers that prevent its adequate compliance.
No takes yet. Share an insight, caveat, or question.
Mantoo et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:
More from Journal of Evolution of Medical and Dental Sciences